Performance of resistive index and semi-quantitative power doppler ultrasound score in predicting acute kidney injury: A meta-analysis of prospective studies.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
04
2022
accepted:
13
06
2022
entrez:
28
6
2022
pubmed:
29
6
2022
medline:
1
7
2022
Statut:
epublish
Résumé
This study aimed to assess the predictive value of the renal resistive index (RRI) and power Doppler ultrasound (PDU) on subsequent acute kidney injury (AKI) risk using a meta-analytic approach. We searched eligible studies in PubMed, EmBase, and the Cochrane library from inception until August 2021. The parameters included the sensitivity, specificity, positive and negative likelihood ratios (PLR and NLR), diagnostic odds ratio (DOR), and area under the receiver operating characteristic curves (AUC). Twenty-three prospective studies involving 2,400 patients were selected. The pooled sensitivity and specificity of the RRI and PDU were 0.76 and 0.79, and 0.64 and 0.90, respectively. The pooled PLR and NLR were 3.64 and 0.31, and 6.58 and 0.40 for the RRI and PDU, respectively. The DORs of the RRI and PDU for predicting AKI were 11.76, and 16.32, respectively. The AUCs of the RRI and PDU for predicting AKI were 0.83, and 0.86, respectively. There were no significant differences between the RRI and PDU for predicting AKI in terms of sensitivity, PLR, NLR, DOR, and AUC. The specificity of the RRI was lower than that of the PDU for predicting AKI. This study found that the predictive performance of the RRI and PDU from the Doppler ultrasound for AKI was similar, which need to be further verified based on the direct comparison results.
Identifiants
pubmed: 35763514
doi: 10.1371/journal.pone.0270623
pii: PONE-D-22-10979
pmc: PMC9239473
doi:
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0270623Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
G Ital Nefrol. 2013 Mar-Apr;30(2):
pubmed: 23832456
J Transl Med. 2022 May 13;20(1):215
pubmed: 35562803
N Z Med J. 2015 Apr 17;128(1412):39-46
pubmed: 25899491
Eur J Clin Invest. 2016 Mar;46(3):242-51
pubmed: 26728776
Kidney Int Suppl (2011). 2012 Mar;2(1):19-36
pubmed: 25018918
BMC Nephrol. 2017 May 3;18(1):151
pubmed: 28468613
J Crit Care. 2015 Jun;30(3):629-35
pubmed: 25746587
Clin Nephrol. 2020 Apr;93(4):172-186
pubmed: 32017700
Crit Care. 2011;15(3):157
pubmed: 21586101
J Crit Care. 2018 Jun;45:204-208
pubmed: 29573604
BMC Med Inform Decis Mak. 2022 Jan 19;22(1):17
pubmed: 35045840
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
BMC Med Res Methodol. 2012 Sep 27;12:150
pubmed: 23016799
J Clin Epidemiol. 2005 Sep;58(9):882-93
pubmed: 16085191
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
JAMA. 2022 Mar 8;327(10):956-964
pubmed: 35258532
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Nurs Clin North Am. 2018 Dec;53(4):499-510
pubmed: 30388976
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
Sci Rep. 2022 Jan 14;12(1):749
pubmed: 35031637
J Crit Care. 2019 Apr;50:36-43
pubmed: 30471559
Ren Fail. 2022 Dec;44(1):43-53
pubmed: 35166177
Clin Chem Lab Med. 2017 Jul 26;55(8):1074-1089
pubmed: 28076311
Dis Markers. 2022 Jan 06;2022:9367873
pubmed: 35035614
Stat Med. 2002 May 15;21(9):1237-56
pubmed: 12111876
Clin J Am Soc Nephrol. 2013 Sep;8(9):1482-93
pubmed: 23744003
Crit Care. 2004 Aug;8(4):R204-12
pubmed: 15312219
Med Decis Making. 2005 Nov-Dec;25(6):646-54
pubmed: 16282215
Cardiol Clin. 2019 Aug;37(3):251-265
pubmed: 31279419
Int Urol Nephrol. 2015 Feb;47(2):405-12
pubmed: 25503640